Nutritional Supplement (NT Factor™) Restores Mitochondrial Function and Reduces Moderately Severe Fatigue in Aged Subjects

Journal of Chronic Fatigue Syndrome

Volumn 11, Issue 3, 2003, Pages 23-36

  Agadjanyan, Michael ^a   Vasilevko, Vitaley ^a   Ghochikyan, Anahit ^a   Berns, Paul ^a   Kesslak, Patrick ^b   Settineri, Robert A ^c   Nicolson, Garth L ^a  

^a INSTITUTE FOR MOLECULAR MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Nutritional Therapeutics Inc   (United States)

Author keywords

Aging; Fatigue; Mitochondrial metabolism; NT Factor

Indexed keywords

ANALGESIC AGENT; ANTIALLERGIC AGENT; ANTIASTHMATIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; MEMBRANE PHOSPHOLIPID; MINERAL; MULTIVITAMIN; NONSTEROID ANTIINFLAMMATORY AGENT; NT FACTOR; PHOSPHATIDYLCHOLINE; PROBIOTIC AGENT; RHODAMINE 123; STOMACH SECRETION INHIBITOR; THYROID HORMONE;

ADULT; AFFECT; AGED; AGING; ARTICLE; BEHAVIOR; CELL FUNCTION; CELL TRANSPORT; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MITOCHONDRION; MOOD; PILOT STUDY; SCORING SYSTEM;

EID: 0142182405     PISSN: 10573321     EISSN: None     Source Type: Journal    
DOI: 10.1300/J092v11n03_03     Document Type: Article

References (26)

1. Kroenke K, Wood DR, Mangelsdorff AD, Meier NJ, Powell JB. Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome. JAMA 1988; 260:929-934.
2. Morrison JD. Fatigue as a presenting complaint in family practice. J Family Pract 1980; 10:795-801.
3. McDonald E, David AS, Pelosi AJ, Mann AH. Chronic fatigue in primary care attendees. Psychol Med 1993; 23:987-998.
4. Piper BF, Linsey AM, Dodd MJ. Fatigue mechanism in cancer. Oncol Nursing Forum 1987; 14:17-23.
5. Richter C, Par JW, Ames B. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Nat Acad Sci USA 1998; 85:6465-6467.
6. Wei YH, Lee HC. Oxidative stress, mitochondrial DNA mutation and impairment of antioxidant enzymes in aging. Exp Biol Med 2002; 227:671-682.
7. Spector AA, Yorek MA. Membrane lipid composition and cellular function. J Lipid Res 1985; 26:10105.
8. Harman D. Aging: A theory based on free radical and radiation chemistry. J Gerontol 1956; 2:298-300.
9. Xu D, Finkel T. A role for mitochondria as potential regulators of cellular life span. Biochem Biophysics Res Commun 2002; 294:245-248.
10. Colodny L, Lynch K, Farber C, Papish S, et al. Results of a study to evaluate the use of Protax to reduce adverse effects of chemotherapy. JANA 2000; 2:17-25.
11. Seidman M, Khan MJ, Tang WX, Quirk WS. Influence of lecithin on mitochondrial DNA and age-related hearing loss. Otolaryngol Head Neck Surg 2002; 127:138-144.
12. Ellithorpe RR, Settineri R, Nicolson GL. Pilot Study: Reduction of fatigue by use of a dietary supplement containing glycophospholipids. JANA 2003; in press.
13. Kim MJ, Cooper DD, Hayes SF, Spangrude GJ. Rhodamine-123 staining in hematopoietic stem cells of young mice indicates mitochondrial activation rather than dye efflux. Blood 1998; 91:4106-4117.
14. Nunnally JC. 1978. Psychometric, Theory (2nd ed.) New York: McGraw-Hill, pp. 117-123.
15. Zeisel SH, In Hanin I, Popell G (eds.) 1996. Phospholipids, biochemical pharmaceutical and analytical considerations. New York: Plenum Press, pp. 219-231.
16. Conlay LA, Wurtman RJ, Blusztajn K, et al. Decreased plasma choline concentrations in marathon runners. N Engl J Med 1986; 315:892.
17. Johns DR. Seminars in medicine of Beth Israel Hospital, Boston: Mitochondrial DNA and Disease. N Engl J Med 1995; 333:638-644.
18. Kowald A. The mitochondrial theory of aging: do damaged mitochondria accumulate by delayed degradation? Exp Gerontol 1999; 34:605-612.
19. Paradies G, Petrosillo G, Pistolese M, Ruggiero F. Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage. Gene 2002; 286:135-141.
20. Lin M, Simon D, Ahn C, Lauren K, Beal MF. High aggregrate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Human Mol Genet 2002; 11:133-145.
21. Koboska J, Coskun P, Esposito L, Wallace DC. Increased mitochondrial oxidative stress in the Sod2(+/-) mouse results in age-related decline of mitochondrial function culminating in increased apoptosis. Proc Nat Acad Sci USA 2001; 98:2278-2283.
22. Biagini G, Pallotti F, Carraro S, et al. Mitochondrial DNA in platelets from aged subjects. Mech Ageing Dev 1998; 101:264-275.
23. Meissner C, Mohamed SA, Klueter H, Hamann K, von Wurmb N, Oehmichen M. Quantification of mitochondrial DNA in human blood cells using an automated detection system. Forensic Sci Int 2000; 113:109-112.
24. Lee HC, Oang CY, Hsu HS, Wei YH. Deletion in blood mitochondrial DNA in Kearns-Sayre syndrome. Biochim Biophys Acta 1994; 1226:37-43.
25. Poulton J, Deadman ME, Ramacharan S, Gardiner RM. Germ-line deletions of mtDNA in mitochondrial myopathy. Am J Hum Genet 1991; 90:649-653.
26. Smith OP, Hamm MJ, Woodward CE, Brockington M. Pearson's marrow/pancreas syndrome: haematological features associated with deletion and duplication of mitochondrial DNA. Br J Haemotol 1995; 90:469-472.